57.09
57.09 (0%)
As of Feb 14, 2025
Vericel Corp [VCEL]
Source:
Company Overview
Vericel Corp is a fully-integrated, commercial-stage biopharmaceutical company and a leading provider of advanced therapies for the sports medicine and severe burn care markets.
| Country | United States |
| Headquarters | cambridge, massachusetts |
| Phone Number | (617) 588-5555 |
| Industry | manufacturing |
| CEO | Dominick C. Colangelo |
| Website | www.vcel.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $237.2 |
| Operating Profit | $4.5 |
| Net Income | $10.4 |
| Net Cash | $-1.8 |
Profit Ratios
| Gross Margin | $172.1 |
| Operating Margin | 1.9 |
| Profit as % of Revenues | 1,660.9% |
| Profit as % of Assets | 2.6% |
| Profit as % of Stockholder Equity | 3.6% |
Management Effectiveness
| Return on Equity | 3.6% |
| Return on Assets | 2.4% |
| Turnover Ratio | 60.3% |
| EBITA | $4.5 |
Balance Sheet and Cash Flow Measures
| Total Assets | $432.7 |
| Total Liabilities | $140.8 |
| Operating Cash Flow | $58.2 |
| Investing Cash Flow | $-79 |
| Financing Cash Flow | $19.1 |
